Topical delivery of antioxidants

Current Drug Delivery

Volumn 8, Issue 6, 2011, Pages 640-660

  Ascenso, Andreia ^a   Ribeiro, Helena Margarida ^a   Marques, Helena Cabral ^a   Simões, Sandra ^a  

^a RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

Author keywords

Antioxidants; Dermal delivery; Drug delivery systems; Topical delivery

Indexed keywords

ACTEOSIDE; ALPHA TOCOPHEROL; ANTIOXIDANT; ARACHIDONIC ACID; ASCORBIC ACID; BETA CAROTENE; BUTYLCRESOL; CAROTENOID; CYCLODEXTRIN; CYTOKINE; DEFEROXAMINE MESYLATE; DNA; EBSELEN; ETHOSOME; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HYDROQUINONE; HYDROXYL RADICAL; LIPOSOME; LYCOPENE; MELATONIN; NANOPARTICLE; NON IONIC SURFACTANT VESICLE; PHYCOCYANIN; REACTIVE OXYGEN METABOLITE; SOLID LIPID NANOPARTICLE; SUPEROXIDE DISMUTASE; TRIAMCINOLONE ACETONIDE; UBIDECARENONE; UBIQUINOL CYTOCHROME C REDUCTASE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACNE; AGING; ALCOHOL CONSUMPTION; ALLERGIC VASCULITIS; ALOPECIA AREATA; ANTIOXIDANT ACTIVITY; ARACHIDONIC ACID METABOLISM; ARTICLE; ATOPIC DERMATITIS; AUTOIMMUNE DISEASE; BEHCET DISEASE; CELL MEMBRANE PERMEABILITY; CYTOKINE RELEASE; DNA DAMAGE; DNA REPAIR; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG PENETRATION; DRUG STABILITY; EDEMA; ENCAPSULATION; ENZYME INACTIVATION; GAMMA IRRADIATION; GRAPE; HUMAN; HYDROPHILICITY; IN VITRO STUDY; IN VIVO STUDY; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; PASSIVE SMOKING; PHOTOSENSITIZATION; PRIORITY JOURNAL; PSORIASIS; REPERFUSION INJURY; ROSACEA; SKIN CANCER; SKIN DEFECT; SKIN DISEASE; SKIN INFLAMMATION; SKIN PROTECTION; STRATUM CORNEUM; SUN EXPOSURE; THERMAL INJURY; ULTRAVIOLET RADIATION;

ADMINISTRATION, TOPICAL; ANIMALS; ANTIOXIDANTS; HUMANS; REACTIVE OXYGEN SPECIES; SKIN DISEASES;

EID: 80054119415     PISSN: 15672018     EISSN: 18755704     Source Type: Journal    
DOI: 10.2174/156720111797635487     Document Type: Article

References (191)

1. Maeda, H.; Akaike, T. Nitric oxide and oxygen radicals in infection, inflammation, and cancer. Biochemistry, 1998, 63, 854-865.
2. Krall, J.; Bagley, A.C.; Mullenbach, G.T.; Hallewell, R.A.; Lynch, R.E. Superoxide mediated the toxicity of paraquat for cultured mammalian cells. J. Biol. Chem., 1988, 263, 1910-1914.
3. Sohal, R.S.; Agarwal, A.; Agarwal, S.; Orr, W.C. Simultaneous overexpression of copper- and zinc-containing superoxide dismutase and catalase retards age-related oxidative damage and increases metabolic potential in Drosophila melanogaster. J. Biol. Chem., 1995, 270, 15671-15674.
4. Ho, Y.-S.; Vincent, R.; Dey, M.S.; Slot, J.W.; Crapo, J.D. Transgenic models for the study of lung antioxidant defense: enhanced manganese-containing superoxide dismutase activity gives partial protection to B6C6 hybrid mice exposed to hyperoxia. Am. J. Respir. Cell Mol. Biol., 1998, 18, 538-547.
5. Jay, V.; Berthon, J.Y.; Hagege, D.; Pouget, M.-P.; Lejeune, B.; Pourrat, H. New active ingredient for aging prevention. Cosmet. Toiletries, 1998, 113, 71-77.
6. Halliwell, B. Reactive oxygen species in living systems: source, biochemistry, and role in human disease. Am. J. Med., 1991, 91, 149-225.
7. Turrens, J.F.; Crapo, J.D.; Freeman, B.A. Protection against oxygen toxicity by intravenous injection of liposome-entrapped catalase and superoxide dismutase. J. Clin. Invest., 1984, 73, 87-95.
8. Cuzzocrea, S.; Riley, D.P.; Caputi, A.P.; Salvemini, D. Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol. Rev., 2001, 53, 135-159.
9. Vessey, D.A. In: Oxidative Stress in Dermatology; Fuchs, J.; Packer, P., Eds.; Marcel Dekker: New York, 1993; pp. 81-104.
10. Maellaro, E.; Del Bello, B.; Sugherini, L.; Santucci, A.; Comporti, M.; Casini, A.F. Purification and characterization of glutathionedependent dehydroascorbic reductase from rat liver. Biochem. J., 1994, 301, 471-476.
11. Stadtman, T.C. Selenium biochemistry. Mammalian selenoenzymes. Ann. N. Y. Acad. Sci., 2000, 899, 399-402.
12. Mayachi, Y. In: Oxidative Stress in Dermatology; Fuchs, J.; Packer, P., Eds.; Marcel Dekker: New York, 1993; pp. 323-332.
13. Fisher, M.S.; Kripke, M.L. Systemic alteration induced in mice by ultraviolet light irradiation and its relationship to ultraviolet carcinogenesis. Bull. World Health Organ., 2002, 80, 908-912.
14. Giacomoni, P.U.; Declercq, L.; Hellemans, L.; Maes, D. Aging of human skin: review of a mechanistic model and first experimental data. IUBMB Life, 2000, 49, 259-263.
15. Elias, P.M.; Feingold, K.R. Lipids and the epidermal water barrier: metabolism, regulation, and pathophysiology. Semin. Dermatol., 1992, 11, 176-182.
16. Mao-Qiang, M.; Jain, M.; Feingold, K.R.; Elias, P.M. Secretory phospholipase A2 activity is required for permeability barrier homeostasis. J. Invest. Dermatol., 1996, 106, 57-63.
17. Noonan, F.P.; De Fabo, E.C. Immunosuppression by ultraviolet B radiation: initiation by urocanic acid. Immunol. Today, 1992, 13, 250-254.
18. Kensler, T.W.; Trush, M.A. Role of oxygen radicals in tumour promotion. Environ. Mutagen., 1984, 6, 593-616.
19. Trouba, K.J.; Hamadeh, H.K.; Amin, R.P.; Germolec, D.R. Oxidative stress and its role in skin disease. Antioxid. Redox Signal., 2002, 4, 665-673.
20. Mittal, A.; Elmets, C.A.; Katuyar, S.K. CD11b+ cells are the major source of oxidative stress in UV radiation-irradiated skin: possible role in photoaging and photocarcinogenesis. Photochem. Photobiol., 2003, 77, 259-264.
21. Fuchs, J.; Zollner, T.M.; Kaufman, R.; Podda, M. Redoxmodulated pathways in inflammatory skin diseases. Free Radic. Biol. Med., 2001, 30, 337-353.
22. Antille, C.; Sorg, O.; Lübbe, J.; Saurat, J.-H. Decreased oxidative state in non-lesional skin of atopic dermatitis. Dermatology., 2002, 204, 69-71.
23. Shvedova, A.A.; Kisin, E.; Kisin, J.; Castranova, V.; Kommineni, C. Elevated oxidative stress in skin of B6C3F1 mice affects dermal exposure to metal working fluid. Toxicol. Ind. Health, 2000, 16, 267-276.
24. Shvedova, A.A.; Kisin, E.; Murray, A.; Smith, C.; Castranova, V.; Kommineni, C. Enhanced oxidative stress in skin of vitamin E deficient mice exposed to semisynthetic metal working fluids. Toxicology, 2002, 176, 135-143.
25. Omata, N.; Tsukahara, H.; Ito, S.; Oshima, Y.; Yasutomi, M.; Yamada, A.; Jiang, M.; Hiraoka, M.; Nambu, M.; Deguchi, Y.; Mayumi, M. Increased oxidative stress in childhood atopic dermatitis. Life Sci., 2001, 69, 223-228.
26. Tsukahara, H.; Shibata, R.; Ohshima, Y.; Todoroki, Y.; Sato, S.; Ohta, N.; Hiraoka, M.; Yoshida, A.; Nishima, S.; Mayumi, M. Oxidative stress and altered antioxidant defenses in children with acute exacerbation of atopic dermatitis. Life Sci., 2003, 72, 2509-2516.
27. Kaur, S.; Zilmer, M.; Eisen, M.; Kullisaar, T.; Rehema, A.; Vihalemm, T. Patients with allergic and irritatant contact dermatitis are characterized by striking change of iron and oxidized glutathione status in nonlesional are of the skin. J. Invest. Dermatol., 2001, 116, 886-890.
28. Briganti, S.; Cristaudo, A.; D'Argento, V.; Cassaro, N.; Turbino, L.; Guarrera, M.; Vera, G.; Picardo, M. Oxidative stress in physical urticarias. Clin. Exp. Dermatol., 2001, 26, 284-288.
29. Yachie, A.; Toma, T.; Mizuno, K.; Okamoto, H.; Shimura, S.; Ohta, K.; Kasahara, Y.; Koizumi, S. Heme oxygenase-1 production by peripheral blood monocytes during acute inflammatory illness of children. Exp. Biol. Med., 2003, 228, 550-556.
30. Öztas, M.O.; Balk, M.; Ögüs, E.; Bozkurt, M.; Ögüst, I.H.; Özer, N. The role of free oxygen radicals in the aetiopathogenesis of rosacea. Clin. Exp. Dermatol., 2003, 28, 188-192.
31. Bang, H.D.; Shin, M.H.; Chung, J.H.; Cho, K.H.; Kim, K.H.; Eun, H.C. Changes of cutaneous antioxidant enzyme activity in allergic contact dermatitis in young and old individuals. Exog. Dermatol., 2002, 1, 296-301.
32. Battino, M.; Ferreiro, M.S.; Quiles, J.L.; Bompadre, S.; Leone, L.; Bullon, P. Alterations in the oxidation products, antioxidant markers, antioxidant capacity and lipid patterns in plasma of patients affected by Papillon-Lefèvre syndrome. Free Radic. Res., 2003, 37, 603-609.
33. Akar, A.; Arca, E.; Erbil, H.; Akay, C.; Sayal, A.; Gü, A.R. Antioxidant enzyme and lipid peroxidation in the scalp of patients with alopecia areata. J. Dermatol. Sci., 2002, 29, 85-90.
34. Young, J.M.; De Young, L.M. In: Pharmacological Methods in the Control of Inflammation; Spector, J.; Back, N., Eds.; Alan R. Liss Inc.: New York, 1989; pp. 215-231.
35. Kotyuk, B.; Raychaudhuri, A.; Dipasquale, G. Effect of antiinflammatory compound on edema formation and myeloperoxidase activity in the arachidonic acid-induced ear model in the mouse. Agents Actions, 1993, 39, C46-C48.
36. Viliksea, M. Characteristics ad modulation of dithranol (anthralin)- induced skin irritation in the mouse ear model. Arch. Dermatol. Res., 1991, 283, 262-268.
37. Willis, C.M.; Reiche, L.; Wilkinson, J.D. Immunocytochemical demonstration of reduced Cu,Zn-superoxide dismutase levels following topical application of dithranol and sodium lauryl sulphate: an indication of the role of oxidative stress in acute irritant contact dermatitis. Eur. J. Dermatol., 1998, 8, 8-12.
38. Trenam, C.W.; Dabbagh, A.J.; Morris, C.J.; Blake, D.R. Skin inflammation induced by reactive oxygen species (ROS): an in vivo model. Brit. J. Dermatol., 1991, 125, 325-329.
39. Kagan, V.E.; Kisin, E.R.; Kawai, K.; Serinkan, B.F.; Osipov, A.N.; Serbinova, E.A.; Wolinsky, I.; Shvedova, A.A. Toward mechanism- based antioxidant interventions: lessons from natural antioxidants. Ann. N.Y. Acad. Sci., 2002, 959, 188-198.
40. Roberfroid, M.B.; Calderon, P.B. In: Oxidative Stress in Dermatology; Fuchs, J.; Packer, P., Eds.; Marcel Dekker: New York, 1993; pp. 392-412.
41. Vessey, D.A.; Lee, K.H. Inactivation of enzymes of the glutathione antioxidant system by treatment of cultured human keratinocytes with peroxides. J. Invest. Dermatol., 1993, 100, 829-833.
42. Emerit, I.; Filipe, P.; Freitas, J.; Fernandes, A.; Garban, F.; Vassy, J. Assaying binding capacity of Cu, ZnSOD and MnSOD: demon stration of their localization in cells and tissues. Method. Enzymol., 2002, 349, 321-327.
43. Fuchs, J.; Schürer, N.; Milbradt, R. In: Oxidative stress in dermatology; Fuchs, J.; Packer, P., Eds.; Marcel Dekker: New York, 1993; pp. 413-456.
44. Thibeault, D.W.; Rezaiekhaligh, M.; Mabry, S.; Beringer, T. Prevention of chronic pulmonary oxygen toxicity in young rats with liposome-encapsulated catalase administered intratracheally. Pediatr. Pulmonol., 1991, 11, 318-327.
45. Welty-wolf, K.E.; Simonson, S.G.; Huang, Y.-C.T.; Kantrow, S.P.; Carraway, M.S.; Chang, L.-Y.; Crapo, J.D.; Piantadosi, C.A. Aerosolized manganese SOD decreases hyperoxic pulmonary injury in primates. II. Morphometric analysis. J. Appl. Physiol., 1997, 83, 559-568.
46. Salvemini, D.; Mazzon, E.; Dugo, L.; Riley, D.P.; Serraino, I.; Caputi, A.P.; Cuzzocrea, S. Pharmacological manipulation of the inflammatory cascade by the superoxide dismutase mimetic, M40403. Br. J. Pharmacol., 2001, 132, 815-827.
47. Prausnitz, M.R. Reversible skin permeabilization for transdermal delivery of macromolecules. Crit. Rev. Ther. Drug Carr. Syst., 1997, 14, 455-483.
48. Cevc, G.; Schätzlein, A.; Richardsen, H. Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers intact. Evidence from double label CLSM experiments and direct size measurements. Biochim. Biophys. Acta, 2002, 1564, 21-30.
49. Baliga, M.S.; Katiyar, S.K. Chemoprevention of photocarcinogenesis by selected dietary botanicals. Photochem. Photobiol. Sci., 2006, 5, 243-253.
50. Pokorny, J. Are natural antioxidants better - and safer - than synthetic antioxidants? Eur. J. Lipid Sci. Technol., 2007, 109, 629-642.
51. Afaq, F.; Mukhtar, H. Botanical antioxidants in the prevention of photocarcinogenesis and photoaging. Exp. Dermatol., 2006, 15, 678-684.
52. Lahiri-Chatterjee, M.; Katiyar, S.K.; Mohan, R.R.; Agarwal, R. A flavonoid antioxidant, silymarin, affords exceptionally high protection against tumour promotion in the SENCAR mouse skin tumourigenesis model. Cancer Res., 1999, 59, 622-632.
53. Katuyar, S.K. Treatment of silymarin, a plant flavonoid, prevents ultraviolet light-induced immune suppression and oxidative stress in mouse skin. Int. J. Oncol., 2002, 21, 1213-1222.
54. Kaflin, R.; Righi, A.; Del Rosso, A.; Bagchi, D.; Generini, S.; Cerinic, M.M.; Das, D.K. Activin, a grape seed-derived proanthocyanidin extract, reduced plasma levels of oxidative stress and adhesion molecules (ICAM-1, VCAM-1, and E-selectin) in systemic sclerosis. Free Radic. Res., 2002, 36, 819-825.
55. Wei, H.; Zhang, X.; Wang, Y.; Lebwohl, M. Inhibition of ultraviolet light-induced oxidative events in the skin and internal organs of hairless mice by isoflavone genistein. Cancer Lett., 2002, 185, 21-29.
56. McArdle, F.; Rhodes, L.E.; Parslew, R.; Jack, C.I.; Friedmann, P.S.; Jackson, M.J. UVR-induced oxidative stress in human skin in vivo: effects of oral vitamin C supplementation. Free Radic. Biol. Med., 2002, 33, 1355-1362.
57. Alam, A.; Khan, N.; Sharma, S.; Saleem, M.; Sultana, S. Chemopreventive effect of Vitis vinifera extract on 12-O-tetradecanoyl- 13phorbol acetate-induced cutaneous oxidative stress and tumour promotion in murine skin. Pharmacol. Res., 2002, 46, 557-564.
58. Murakami, A.; Nakamura, Y.; Koshimizu, K.; Takahashi, D.; Matsumoto, K.; Hagihara, K.; Taniguchi, H.; Nomura, E.; Hosoda, A.; Tsuno, T.; Maruta, Y.; Kim, H.W.; Kawabata, K.; Ohigashi, H. FA15, a hydrophobic derivative of ferulic acid, suppresses inflammatory responses and skin tumour promotion: comparison with ferulic acid. Cancer Lett., 2002, 180, 121-129.
59. Pinnell, S.R. Cutaneous photodamage, oxidative stress, and topical antioxidant protection. J. Am. Acad. Dermatol., 2003, 48, 1-19.
60. Lin, J.-Y.; Selim, M.A.; Shea, C.R.; Grichnik, J.M.; Omar, M.M.; Monteiro-Riviere, N.A.; Pinnell, S.R. UV photoprotection by combination topical antioxidants vitamin C and vitamin E. J. Am. Acad. Dermatol., 2003, 48, 866-874.
61. Kramer, K.A.; Liebler, D.C. UVB induced photooxidation of vitamin E. Chem. Res. Toxicol., 1997, 10, 219-224.
62. Lopez-Torres, M.; Thiele, J.J.; Shindo, Y.; Han, D.; Packer, L. Topical application of alpha-tocopherol modulates the antioxidant network and diminishes ultraviolet-induced oxidative damage in murine skin. Br. J. Dermatol., 1998, 138, 207-215.
63. Pinelli, A.; Trivulzio, S.; Tomasoni, L.; Bertolini, B.; Pinelli, G. High-dose vitamin E lowers porphyrin levels in patients affected by porphyria cutanea tarda. Pharmacol. Res., 2002, 45, 355-359.
64. Gensler, H.L.; Magdaleno, M. Topical vitamin E inhibition of immunosuppression and tumourigenesis induced by ultraviolet irradiation. Nutr. Cancer, 1991, 15, 97-106.
65. Yuen, K.S.; Halliday, G.M. Alpha-Tocopherol, an inhibitor of epidermal lipid peroxidation, prevents ultraviolet radiation from suppressing the skin immune system. Photochem. Photobiol., 1997, 65, 587-592.
66. Rijnkels, J.M.; Moison, R.M.; Podda, E.; van Henegouwen, G.M. Photoprotection by antioxidants against UVB-radiation-induced damage in pig skin organ culture. Radiat. Res., 2003, 159, 210-217.
67. Noonan, F.P.; De Fabo, E.C. Immunosuppression by ultraviolet B radiation: initiation by urocanic acid. Immunol. Today, 1992, 13, 250-254.
68. Koone, M.D.; Black, H.S. A mode of action for butylated hydroxytoluene-mediated photoprotection. J. Invest. Dermatol., 1986, 87, 343-347.
69. Reeve, V.E.; Bosnic, M.; Boehm-Wilcox, C. Dependence of photocarcinogenesis and photoimmuno suppression in the hairless mouse on dietary polyunsaturated fat. Cancer Lett., 1996, 108, 217-219.
70. Rhodes, L.E.; Shahbakhti, H.; Azurdia, M.; Moison, R.M.W.; Steenwinkel, M.-J.S.T.; Homburg, M.I.; Dean, M.P.; McArdle, F.; van Henegouwen, G.M.J.B.; Epe, B.; Vink, A.A. Effect of eiacosapentanoic acid, an omega-3 polyunsaturated fatty acid, on UVRrelated cancer risk in humans. An assessment of early genotoxic markers. Carcinogenesis, 2003, 24, 919-925.
71. Yeh, S.L.; Huang, C.S.; Hu, M.L. Lycopene enhances UVAinduced DNA damage and expression of heme oxygenase-1 in cultured mouse embryo fibroblasts. Eur. J. Nutr., 2005, 44, 365-370.
72. Fazekas, Z.; Gao, D.; Saladi, R.N.; Lu, Y.; Lebwohl, M.; Wei, H. Protective effects of lycopene against ultraviolet B-induced photodamage. Nutr. Cancer, 2003, 47, 181-187.
73. Ribaya-Mercado, J.D.; Garmyn, M.; Gilchrest, B.A.; Russell, R.M. Skin lycopene is destroyed preferentially over beta-carotene during ultraviolet irradiation in humans. J. Nutr., 1995, 125, 1854-1859.
74. Di Mascio, P.; Kaiser, S.; Sies, H. Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch. Biochem. Biophys., 1989, 274, 532-538.
75. Simões, S.I.; Delgado, T.C.; Lopes, R.M.; Jesus, S.; Ferreira, A.A.; Morais, J.A.; Cruz, M.E.M.; Corvo, M.L.; Martins, M.B.F. Developments in the rat adjuvant arthritis model and its use in therapeutic evaluation of novel non-invasive treatment by SOD in Transfersomes. J. Control. Release, 2005, 103, 419-434.
76. Vorauer-Uhl, K.; Furnschlief, E.; Wagner, A.; Ferko, B.; Katinger, H. Topically applied liposome encapsulated superoxide dismutase reduces postburn wound size and edema formation. Eur. J. Pharm. Sci., 2001, 17, 63-67.
77. Peus, D.; Mevs, A.; Vasa, R.A.; Beyerle, A.; O'Brien, T.; Pittelkow, M.R. H2O2 is required for UVB-induced EGF receptor and down stream signaling pathway activation. Free Rad. Biol. Med., 1999, 27, 1197-1202.
78. Filipe, P.; Emerit, I.; Vassy, J.; Rigaut, J.P.; Martin, E.; Freitas, J.; Fernandes, A. Epidermal localization and protective effects of topically applied superoxide dismutase. Exp. Dermatol., 1997, 6, 116-121.
79. Yarosh, D.; Bucana, C.; Cox, P.; Alas, L.; Kibitel, J.; Kripke, M. Localization of liposomes containing a DNA repair enzyme in murine skin. J. Invest. Dermatol., 1994, 103, 461-468.
80. Sasaki, H.; Akamatsu, H.; Horio, T. Protective role of copper, zinc superoxide dismutase against UVB-induced injury of the human keratinocyte cell line HaCaT. J. Invest. Dermatol., 2000, 144, 502-507.
81. Mizushima, Y.; Hoshi, K.; Yanagawa, A.; Takano, K. Topical application of superoxide dismutase cream. Drugs Expl. Clin. Res., 1991, 17, 127-131.
82. Thomson, P.D.; Till, G.O.; Woolliscroft, J.O.; Smith, D.J.; Presad, J.K. Superoxide dismutase prevents lipid peroxidation in burned patients. Burns, 1990, 16, 406-408.
83. Lefaix, J.-L.; Delanian, S.; Leplate, J.-J.; Tricaud, Y.; Martin, M.; Nimrod, A.; Baillet, F.; Daburone, F. Successful treatment of radiation-induced fibrosis using Cu,Zn-SOD and Mn-SOD: an experimental study. Int. J. Radiation Oncol. Biol. Phys., 1996, 35, 305-312.
84. Ono, Y.; Miyachi, Y.; Moriguchi, T. In: Evaluation of Topical SOD Treatment on Experimental Burn. In: Proceedings of the 5th International Conference of Oxygen Radicals, Active Oxygen, Lipid Peroxides and Antioxidants, Kyoto, Japan, November 17-21,1991; Yagi, K.; Kondo, M.; Niki, E.; Yoshikawa, T., Eds.; Elsevier Science Ltd: Oxford, UK, 1992, pp. 581-584.
85. Kaur, I.P.; Kapila, M.; Agrawal, R. Role of novel delivery systems in developing topical antioxidants as therapeutics to combat photoageing. Ageing Res. Rev., 2007, 6, 271-288.
86. KNovel®. Skin Aging Handbook - An Integrated Approach to Biochemistry and Product Development. http://www.kno-vel.com/web/portal/browse/display?_EXT_KNOVEL_DISPLAY_boo kid=2291 (Accessed November 1, 2009)
87. Eichler, O.; Sies, H.; Stahl, W. Divergent optimum levels of lycopene, β-carotene and lutein protecting against UVB irradiation in human fibroblasts. Photochem. Photobiol., 2002, 75, 503-506.
88. Bowen, P.; Chen, L.; Stacewicz-Sapuntzakis, M.; Duncan, C.; Sharifi, R.; Ghosh, L.; Kim, H.-S., Christov-Tzelkov, K.; van Breemen, R. Tomato sauce supplementation and prostate cancer: lycopene accumulation and modulation of biomarkers of carcinogenesis. Exp. Biol. Med., 2002, 227, 886-893.
89. Machado, M.; Salgado, T.M.; Hadgraft, J.; Lane, M.E. The relationship between transepidermal water loss and skin permeability. Int. J. Pharm., 2010, 384, 73-77.
90. Cevc, G.; Gebauer, D. Hydration-driven transport of deformable lipid vesicles through fine pores and the skin barrier. Biophys. J., 2003, 84, 1010-1024.
91. Xiong, G.L.; Quan, D.; Maibach, H.I. Effects of penetration enhancers on in vitro percutaneous absorption of low molecular weight heparin through human skin. J. Control. Release, 1996, 42, 289-296.
92. Bonina, F.P.; Montenegro, L. Penetration enhancer effects on in vitro percutaneous absorption of heparin sodium salt. Int. J. Pharm., 1992, 82, 171-177.
93. Weaver, J.C.; Vanbever, R.; Vaughan, T.E.; Prausnitz, M.R. Heparin alters transdermal transport associated with electroporation. Biochem. Biophys. Res. Commun., 1997, 234, 637-640.
94. Palma, S.; Manzo, R.; Lo Nostro, P.; Allemandi, D. Nanostructures from alkyl vitamin C derivatives (ASCn): Properties and potential platform for drug delivery. Int. J. Pharm., 2007, 345, 26-34.
95. Mavon, A.; Raufast, V.; Redoulès, D. Skin absorption and metabolism of a new vitamin E prodrug, y-tocopherol-glucoside: in vitro evaluation in human skin models. J. Control. Release, 2004, 100, 221-231.
96. Abdulmajed, K.; Heard, C.M. Topical delivery of retinyl ascorbate. 3. Influence of follicle sealing and skin stretching. Skin Pharmacol. Physiol., 2008, 21, 46-49.
97. Huang, Z.-R.; Hung, C.-F.; Lin, Y.-K.; Fang, J.-Y. In vitro and in vivo evaluation of topical delivery and potential dermal use of soy isoflavones genistein and daidzein. Int. J. Pharm., 2008, 364, 36-44.
98. Gouranton, E.; El Yazidi, C.; Cardinault, N.; Amiot, M.; Borel, P.; Landrier, J.-F. Purified low-density lipoprotein and bovine serum albumin efficiency to internalise lycopene into adipocytes. Food Chem. Toxicol., 2008, 46, 3832-3836.
99. Richert, S.; Schrader, A.; Schrader, K. Transdermal delivery of two antioxidants from different cosmetic formulations. Int. J. Cosmet. Sci., 2003, 25, 5-13.
100. Cassano, R.; Trombino, S.; Muzzalupo, R.; Tavano, L.; Picci, N. A novel dextran hydrogel linking trans-ferulic acid for the stabilization and transdermal delivery of vitamin E. Eur. J. Pharm. Biopharm., 2009, 72, 232-238.
101. Lambert, J.D.; Kim, D.H.; Zheng, R.; Yang, C.S. Transdermal delivery of (-)-epigallocatechin-3-gallate, a green tea polyphenol, in mice. J. Pharm. Pharmacol., 2006, 58, 599-604.
102. Hung, C.-F.; Lin, Y.-K.; Huang, Z.-R.; Fang, J.-Y. Delivery of resveratrol, a red wine polyphenol, from solutions and hydrogels via the skin. Biol. Pharm. Bull., 2008, 31, 955-962.
103. Han, B.; Nimni, M.E. Transdermal Delivery of Amino Acids and Antioxidants Enhance Collagen Synthesis: In Vivo and In Vitro Studies. Connective Tissue Res., 2005, 46, 251-257.
104. Choquenet, B.; Couteau, C.; Paparis, E.; Coiffard, L.J. Flavonoids and polyphenols, molecular families with sunscreen potential: determining effectiveness with an in vitro method. Nat. Prod. Commun., 2009, 4, 227-230.
105. Zhai, H.; Behnam, S.; Villarama, C.D.; Arens-Corell, M.; Choi, M.J.; Maibach, H.I. Evaluation of the antioxidant capacity and preventive effects of a topical emulsion and its vehicle control on the skin response to UV exposure. Skin Pharmacol. Physiol., 2005, 18, 288-293.
106. Oresajo, C.; Stephens, T.; Hino, P.D; Law, R.M.; Yatskayer, M.; Foltis, P.; Pillai, S.; Pinnell, S.R. Protective effects of a topical antioxidant mixture containing vitamin C, ferulic acid, and phloretin against ultraviolet-induced photodamage in human skin. J. Cosmet. Dermatol., 2008, 7, 290-297.
107. Murray, J.C.; Burch, J.A.; Streilein, R.D.; Iannacchione, M.A.; Hall, R.P.; Pinnell, S.R. A topical antioxidant solution containing vitamins C and E stabilized by ferulic acid provides protection for human skin against damage caused by ultraviolet irradiation. J. Am. Acad. Dermatol., 2008, 59, 418-425.
108. Lin, J.Y.; Tournas, J.A.; Burch, J.A.; Monteiro-Riviere, N.A.; Zielinski, J. Topical isoflavones provide effective photoprotection to skin. Photodermatol. Photoimmunol. Photomed., 2008, 24, 61-66.
109. Gaspar, L.R.; Campos, P.M. Photostability and efficacy studies of topical formulations containing UV-filters combination and vitamins A, C and E. Int. J. Pharm., 2007, 343, 181-189.
110. Grimes, P.E. An efficacy study of 3 commercially available hydroquinone 4% treatments for melasma. Cutis, 2007, 80, 497-502.
111. Vicentini, F.T.M.C.; Simi, T.R.M.; Del Ciampo, J.O.; Wolga, N.O.; Pitol, D.L.; Iyomasa, M.M.; Bentley, M.V.L.B.; Fonseca, M.J.V. Quercetin in w/o microemulsion: In vitro and in vivo skin penetration and efficacy against UVB-induced skin damages evaluated in vivo. Eur. J. Pharm. Biopharm., 2008, 69, 948-957.
112. Casagrande, R.; Georgetti, S.R.; Verri, W.A. Jr.; Dorta, D.J.; dos Santos, A.C.; Fonseca, M.J. Protective effect of topical formulations containing quercetin against UVB-induced oxidative stress in hairless mice. J. Photochem. Photobiol. B, 2006, 84, 21-27.
113. Rozman, B.; Gasperlin, M. Stability of vitamins C and E in topical microemulsions for combined antioxidant therapy. Drug Deliv., 2007, 14, 235-245.
114. Dreher, F.; Maibach, H. Protective effects of topical antioxidants in humans. Curr. Probl. Dermatol., 2001, 29, 157-164.
115. Villiers, A. Sur la transformation de la fécule en dextrine par le ferment butyrique, Compt. Rend. Fr. Acad. Sci., 1891, 435-438.
116. Brewster, M.E.; Loftsson, T. Cyclodextrins as pharmaceutical solubilizers. Adv. Drug Del. Rev., 2007, 59, 645-666.
117. Lopez-Nicolas, J.M.; Perez-Lopez, A.J.; Carbonell-Barrachina, A.; Garcia-Carmona, F. Use of natural and modified cyclodextrins as inhibiting agents of peach juice enzymatic browning. J. Agri. Food Chem., 2007, 55, 5312-5319.
118. Davis, M.E.; Brewster, M.E. Cyclodextrin-based pharmaceutics: past, present and future. Nat. Rev. Drug Discov., 2004, 3, 1023-1035.
119. Thompson, D.O. In: Encyclopedia of Pharmaceutical Technology; James-Swarbrick, James-C.-Boylan, Eds.; Marcel Dekker: New York, 2002; pp. 531-558.
120. Uekama, K. Design and evaluation of cyclodextrin-based drug formulation. Chem. Pharm. Bull., 2004, 52, 900-915.
121. Cabral Marques, H.M. Structure and properties of cyclodextrins. Inclusion complex formation. Rev. Port. Farm., 1994, XLIV, 77-84.
122. Pothakamury, U.R.; Barbosa-Gnovas G.V. Fundamental aspects of controlled release in foods. Trends Food Sci. Technol., 1995, 6, 397-406.
123. Cabral Marques H.M. Preparation of complexes. Evidence for complex formation. Rev. Port. Farm., 1994, XLIV, 157-163.
124. Challa, R.; Ahuja, A.; Ali, J.; Khar, R. Cyclodextrins in drug delivery: an updated review. AAPS PharmSciTech., 2005, 6, E329-E357.
125. th International Cyclodextrin Symposium, Kyoto, Japan, May 8-11, 2008, pp. 312-315.
126. Cabral Marques, H.M. Applications of cyclodextrins. Thermodynamic aspects of cyclodextrin complexes. Rev. Port. Farm., 1994, XLIV, 85-96.
127. Szente, L.; Szejtli, J. Cyclodextrins as food ingredients. Trends Food Sci. Technol., 2004, 15, 137-142.
128. Mourtzinos, I.; Kalogeropoulos, N.; Papadakis, S.E.; Konstantinou, K.; Karathanos, V.T. Encapsulation of nutraceutical monoterpenes in beta-cyclodextrin and modified starch. J. Food Sci., 2008, 73, S89-S94.
129. Loftsson, T.; Masson M. Cyclodextrins in topical drug formulations: theory and practice. Int. J. Pharm., 2001, 225, 15-30.
130. Loftsson, T.; Bodor, N. Effects of 2-hydroxypropyl-β-cyclodextrin on the aqueous solubility of drugs and transdermal delivery of 17β-oestradiol. Acta Pharm. Nord., 1989, 1, 185-194.
131. Uekama, K. Pharmaceutical applications of methylated cyclodextrins. Pharm. Int., 1985, 3, 61-65.
132. McCormack, B.; Gregoriadis, G. Entrapment of cyclodextrin-drug complexes into liposomes: potential advantages in drug delivery. J. Drug Target, 1994, 2, 449-454.
133. Gillet, A.; Grammenos, A.; Compère, P.; Evrard, B.; Piel, G. Development of a new topical system: drug-in-cyclodextrin-indeformable liposome. Int. J. Pharm., 2009, 380, 174-180.
134. Koontz, J.L.; Marcy, J.E.; O'Keefe, S.F.; Duncan, S.E. Cyclodextrin inclusion complex formation and solid-state characterization of the natural antioxidants alpha-tocopherol and quercetin. J. Agric. Food Chem., 2009, 57, 1162-1171.
135. Vertzoni, M.; Kartezini, T.; Reppas, C.; Archontaki, H.; Valsami, G. Solubilization and quantification of lycopene in aqueous media in the form of cyclodextrin binary systems. Int. J. Pharm., 2006, 309, 115-122.
136. Lee, B.J.; Cui, J.H.; Parrott, K.A.; Ayres, J.W.; Sack, R.L. Percutaneous absorption and model membrane variations of melatonin in aqueous-based propylene glycol and 2-hydroxypropylbeta-cyclodextrin vehicles. Arch. Pharm. Res., 1998, 21, 503-507.
137. Soares, L.A.; Leal, A.F.V.B.; Fraceto, L.F.; Maia, E.R.; Resck, I.S.; Kato, M.J.; Gil, E.S.; Sousa, A.R.; Cunha, L.C.; Rezende, K.R. Host-guest system of 4-nerolidylcatechol in 2-hydroxypropyl-β- cyclodextrin: preparation, characterization and molecular modelling. J. Incl. Phenom. Macrocycl. Chem., 2009, 64, 23-35.
138. Davaran, S.; Hanaee, J.; Rashidi, M.R.; Valiolah, F.; Hashemi, M. Influence of poly(ethylene glycol)-alpha-cyclodextrin complexes on stabilization and transdermal permeation of ascorbic acid. J. Biomed. Mater. Res. A, 2006, 78, 590-594.
139. Schwingel, L.; Fasolo, D.; Holzschuh, M.; Lula, I.; Sinisterra, R.; Koester, L.; Teixeira, H.; Bassani, V.L. Association of 3-Omethylquercetin with β-cyclodextrin: complex preparation, characterization and ex vivo skin permeation studies. J. Incl. Phenom. Macrocycl. Chem., 2008, 62, 149-159.
140. Petit, L.; Piérard, G.E. Analytic quantification of solar lentigines lightening by a 2% hydroquinone-cyclodextrin formulation. J. Eur. Acad. Dermatol. Venereol., 2003, 17, 546-549.
141. Chen, X.; Chen, R.; Guo, Z.; Li, C.; Li, P. The preparation and stability of the inclusion complex of astaxanthin with β-CyD. Food Chem., 2007, 101, 1580-1584.
142. Centini, M.; Maggiore, M.; Casolaro, M.; Andreassi, M.; Facino, R.M.; Anselmi, C. Cyclodextrins as cosmetic delivery systems. J. Incl. Phenom. Macrocycl. Chem., 2007, 57, 109-112.
143. Vyas, A.; Saraf, Sh.; Saraf, SW. Cyclodextrin based novel drug delivery systems. J. Incl. Phenom. Macrocycl. Chem., 2008, 62, 23-42.
144. Cevc, G. Lipid vesicles and other colloids as drug carriers on the skin. Adv. Drug Deliv. Rev., 2004, 56, 675-711.
145. Bowstra, J.A.; Honeywell-Nguyen, P.L.; Gooris, G.S.; Ponec, M. Structure of the skin barrier and its modulation by vesicular formulations. Progress Lipid Res., 2003, 42, 1-36.
146. Yarosh, D.B. Liposomes in investigative dermatology. Photodermatol. Photoimmunol. Photomed., 2001, 17, 203-212.
147. El Maghraby, G.M.; Barry, B.W.; Williams, A.C. Liposomes and skin: From drug delivery to model membranes. Eur. J. Pharm. Sci., 2008, 34, 203-222.
148. Gregoriadis, G. Liposome Technology: Preparation of Liposomes, CRC Press: Florida, 1984, Vol 1.
149. Barenholz, Y.; Crommelin, D.J.A. In: Encyclopedia of pharmaceutical technology; James-Swarbrick, James-C.-Boylan, Eds.; Marcel Dekker: New York, 1994; Vol. 9, pp. 1-39.
150. Gray, G.M.; White, R.J. Epidermal lipid liposomes: a novel nonphospholipid membrane system. Biochem. Soc. Trans., 1973, 7, 1129-1131.
151. Mezei, M.; Gulasekharam, V. Liposomes - a selective drug delivery system for the topical route of administration: lotion dosage form. Life Sci., 1980, 26, 1473-1477.
152. Gesztes, A.; Mezei, M. Topical anaesthesia of the skin by liposome-encapsulated tetracaine. Anesth. Analg., 1988, 67, 1079-1081.
153. Du Plessis, J.; Weiner, N.; Müller, D.G. The influence of in vivo treatment of skin with liposomes on the topical absorption of a hydrophilic and a hydrophobic drugs in vitro. Int. J. Pharm., 1994, 103, R1-R2.
154. Padamwar, M.N.; Pokharkar, V.B. Development of vitamin loaded topical liposomal formulation using factorial design approach: Drug deposition and stability. Int. J. Pharm., 2006, 320, 37-44.
155. Manconia, M.; Pendás, J.; Ledón, N.; Moreira, T.; Sinico, C.; Saso, L.; Fadda, A.M. Phycocyanin liposomes for topical antiinflammatory activity: in-vitro in-vivo studies. J. Pharm. Pharmacol., 2009, 61, 423-430.
156. Sinico, C.; Caddeo, C.; Valenti, D.; Fadda, A.M.; Bilia, A.R.; Vincieri, F.F. Liposomes as carriers for verbascoside: stability and skin permeation studies. J. Liposome Res., 2008, 18, 83-90.
157. Lauer, A.C.; Lieb, L.M.; Ramachandran, C.; Flynn, G.L.; Weiner, N.D. Transfollicular drug delivery. Pharm. Res., 1995, 12, 179-186.
158. Simões, S.; Marques, C.; Cruz, M.E.; Martins, M.B. Antiinflammatory effects of locally applied enzyme-loaded ultradeformable vesicles on an acute cutaneous model. J. Microencapsul., 2009, 26, 649-658.
159. Löbbecke, L.; Cevc, G. Effects of short-chain alcohols on the phase behaviour and interdigitation of phosphatidylcholine bilayer membranes. Biochim. Biophys. Acta, 1995, 1237, 59-69.
160. Godin, B.; Touitou, E. Ethosomes: new prospects in transdermal delivery. Crit. Rev. Ther. Drug Carrier Syst., 2003, 20, 63-102.
161. Esposito, E.; Menegatti, E.; Cortesi, R. Ethosomes and liposomes as topical vehicles for azelaic acid: a preformulation study. Int. J. Cosm. Sci., 2004, 26, 270-271.
162. Fang, J.-Y.; Hwang, T.-L.; Huang, Y.-L.; Fang, C.-L. Enhancement of the transdermal delivery of catechins by liposomes incorporating anionic surfactants and ethanol. Int. J. Pharm., 2006, 310, 131-138.
163. Van der Bergh, B.A.I.; Vroom, J.; Gerritsen, H.; Junginger, H.E.; Bowstra J.A. Interactions of elastic and rigid vesicles with human skin in vitro: electron microscopy and two-photon excitation microscopy. Biochim. Biophys. Acta, 1999, 1461, 155-173.
164. Hofland, H.E.J. Vesicles as transdermal drug delivery systems. PhD Thesis, Leiden University, The Netherlands, 1992.
165. Biju, S.S.; Talegaonkar, S.; Mishra, P.R.; Khar R.K. Vesicular systems: an overview. Indian J. Pharm. Sci., 2006, 68, 141-153.
166. Manconi, M.; Sinico, C.; Valenti, D.; Lai, F.; Fadda, A.M. Niosomes as carriers for tretinoin. III. A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin. Int. J. Pharm., 2006, 311, 11-19.
167. Palozza, P.; Muzzalupo, R.; Trombino, S.; Valdannini, A.; Picci, N. Solubilization and stabilization of beta-carotene in niosomes: delivery to cultured cells. Chem. Phys. Lipids., 2006, 139, 32-42.
168. Muzzalupo, R.; Tavano, L.; Trombino, S.; Cassano, R.; Picci, N.; La Mesa, C. Niosomes from alpha,omega-trioxyethylenebis(sodium 2-dodecyloxy-propylenesulfonate): Preparation and characterization. Colloid. Surface. B, 2008, 64, 200-207.
169. Manconi, M.; Valenti, D.; Sinico, C.; Lai, F.; Loy, G.; Fadda, A.M. Niosomes as carriers for tretinoin. II. Influence of vesicular incorporation on tretinoin photostability. Int. J. Pharm., 2003, 260, 261-272.
170. Caraf, M.; Santucci, E.; Lucania, G. Lidocaine-loaded non-ionic
171. Niemiec, S.M.; Ramachandran, C.; Weiner, N. Influence of nonionic liposomal composition on topical delivery of peptide drugs into pilosebaceous units: An in vivo study using the hamster ear model. Pharm. Res., 1995, 12, 1184-1188.
172. Müller, R.H.; Mäder, K.; Gohla, S. Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur. J. Pharm. Biopharm., 2000, 50, 161-177.
173. Pardeike, J.; Hommoss, A.; Müller, R.H. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int. J. Pharm., 2009, 366, 170-184.
174. Müller, R.H.; Radtke, M.; Wissing, S.A. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv. Drug Deliv. Rev., 2002, 54, S131-S155.
175. Ochekpe, N.A.; Olorunfemi, P.O.; Ngwuluka, N.C. Nanotechnology and drug delivery, Part 2: Nanostructures for drug delivery. Tropical J. Pharm. Res., 2009, 8, 257-287.
176. Mehnert, W.; Mäder, K. Solid lipid nanoparticles production, characterization and applications. Adv. Drug Del. Rev., 2001, 47, 165-196.
177. Hsu, C.-H.; Cui, Z.; Mumper, R.J.; Jay, M. Preparation and characterization of novel coenzyme Q10 nanoparticles engineered from microemulsion precursors. AAPS PharmSciTech., 2003, 4, 1-12.
178. Kwon, S.S.; Nam, Y.S.; Lee, J.S.; Ku, B.S.; Han, S.H.; Lee, J.Y.; Chang, I.S. Preparation and characterization of coenzyme Q10- loaded PMMA nanoparticles by a new emulsification process based on microfluidization. Colloid. Surface. A., 2002, 210, 95-104.
179. Teeranachaideekul, V.; Souto, E.B.; Junyaprasert, V.B.; Müller, R.H. Cetyl palmitate-based NLC for topical delivery of Coenzyme Q(10) - development, physicochemical characterization and in vitro release studies. Eur. J. Pharm. Biopharm., 2007, 67, 141-148.
180. Liu, J.; Hu, W.; Chen, H.; Ni, Q.; Xu, H.; Yang, X. Isotretinoinloaded solid lipid nanoparticles with skin targeting for topical delivery. Int. J. Pharm., 2007, 328, 191-195.
181. Castro, G.A.; Ferreira, L.A.M. Characterization of a new solid lipid nanoparticle formulation containing retinoic acid for topical treatment of acne. Powder Diffr., 2008, 23, S30-S35.
182. Lee, C.-M.; Jeong, H.-J. Temperature-induced release of all-transretinoic acid loaded in solid lipid nanoparticles for topical delivery. Macromol. Res., 2008, 16, 682-685.
183. Jenning, V.; Schäfer-Korting, M.; Gohla, S. Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties. J. Control. Release, 2000, 66, 115-126.
184. Shaha, K.A.; Datea, A.A.; Joshia, M.D.; Patravale, V.B. Solid lipid nanoparticles (SLN) of tretinoin: Potential in topical delivery. Int. J. Pharm., 2007, 345, 163-171.
185. Souto, E.B.; Müller, R.H.; Gohla, S. A novel approach based on lipid nanoparticles (SLN®) for topical delivery of α-lipoic acid. J. Microencapsul., 2005, 22, 581-592.
186. Ruktanonchai, U.; Bejrapha, P.; Sakulkhu, U.; Opanasopit, P.; Bunyapraphatsara, N., Junyaprasert, V.; Puttipipatkhachorn, S. Physicochemical characteristics, cytotoxicity, and antioxidant activity of three lipid nanoparticulate formulations of alpha-lipoic acid. AAPS PharmSciTech., 2009, 10, 227-234.
187. Wissing, S.A.; Müller, R.H. Solid lipid nanoparticles (SLN)-a novel carrier for UV blockers. Pharmazie, 2001, 56, 783-786.
188. Song, C.; Liu, S. A new healthy sunscreen system for human: solid lipid nanoparticles as carrier for 3,4,5-trimethoxybenzoylchitin and the improvement by adding Vitamin E. Int. J. Biol. Macromol. 2005, 36, 116-119.
189. Zhao, Y.; Brown, M.B.; Jones, S.A. Pharmaceutical foams: are they the answer to the dilemma of topical nanoparticles? Nanomedicine, 2010, 6, 227-236.
190. Zhao, Y.; Moddaresi, M.; Jones, S.A.; Brown, M.B. A dynamic topical hydrofluoroalkane foam to induce nanoparticle modification and drug release in situ. Eur. J. Pharm. Biopharm., 2009, 72, 521-528.
191. Constantinides, P.P.; Han, J.; Davis, S.S. Advances in the use of tocols as drug delivery vehicles. Pharm. Res., 2006, 23, 243-255.